Liang Jin

Dr. Liang Jin


Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
9 April 2020 in Radiation Oncology
Verified
Journal Article
Open access
PDF file
LJLiang Jin
Liang Jin
NSNing Shi
Ning Shi
SRShiye Ruan
Shiye Ruan
BHBaohua Hou
Baohua Hou
YZYiping Zou
Yiping Zou
ZJZhixiang Jian
Zhixiang Jian
Purpose: Several studies investigating the role of intraoperative radiotherapy (IORT) in the treatment of resectable pancreatic cancer (PC) have been published; however, their results remain inconsistent. By conducting a systematic review and meta-analysis, this study aimed to compare clinical outcomes in patients with resectable PC who underwent surgery with or without IORT. Methods and materials: The MEDLINE/PubMed, EMBASE, and Cochrane Library databases were searched to identify relevant studies published up to February 28, 2019. The main outcome measures included median survival time (MST), local recurrence (LR), postoperative complications, and operation-related mortality. Pooled effect estimates were obtained by performing a random-effects meta-analysis. Results: A total of 1095 studies were screened for inclusion, of which 15 studies with 834 patients were included in the meta-analysis. Overall, 401 patients underwent pancreatic resection with IORT and 433 underwent surgery without IORT. The pooled analysis revealed that IORT group experienced favorable overall survival (median survival rate [MSR], 1.20; 95% confidence interval [CI], 1.06–1.37, P = 0.005), compared with patients who did not receive IORT. Additionally, the pooled data showed a significantly reduced LR rate in the IORT group compared with that in the non-IORT group (relative risk [RR], 0.70; 95% CI, 0.51–0.97, P = 0.03). The incidences of postoperative complications (RR, 0.95; 95% CI, 0.73–1.23) and operation-related mortality (RR, 1.07; 95% CI, 0.44–2.63) were similar between the IORT and non-IORT groups. Conclusion: IORT significantly improved locoregional control and overall survival in patients with resectable PC, without increasing postoperative complications and operation-related mortality rates.

1 January 2023 in Contemporary Oncology
Verified
Journal Article
Open access
PDF file
LJLiang Jin
Liang Jin
XZXiaojing Zhang
Xiaojing Zhang
MFMing Fan
Ming Fan
WLWeimin Li
Weimin Li
XZXuan Zhang
Xuan Zhang
Introduction: Mutations of kinetochore-localized astrin/sperm-associated antigen 5 (KNSTRN) can interfere with chromatid cohesion, increase aneuploidy in tumours, and enhance tumourigenesis. However, the role of the KNSTRN-binding protein in hepatocellular carcinoma (HCC) remains unclear....

26 June 2023 in Research Square
Verified
Preprint
Open access
PDF file
LJLiang Jin
Liang Jin
XZXiaojing Zhang
Xiaojing Zhang
MFMing Fan
Ming Fan
WLWeimin Li
Weimin Li
QLQuanyou Lai
Quanyou Lai
XZXuan Zhang
Xuan Zhang
Background Kinetochore localized astrin/SPAG5 binding protein (KNSTRN) plays an important molecular in cell division. Mutations of KNSTRN can interfere with chromatid cohesion, increase aneuploidy in tumors, enhancing tumorigenesis. Additionally, the concept of nuclear activating miRNA (NamiRNA) has been proposed with encouraging results. However, the role of KNSTRN in Hepatocellular Carcinoma (HCC) remains not fully determined, and the underlying molecular mechanisms of this differential regulation of KNSTRN by a NamiRNA are also unclear in HCC. Methods Based on Gene Expression Omnibus (GEO) and The Cancer Genome Atlas (TCGA) databases, we first investigated the potential oncogenic functions of KNSTRN and a potential NamiRNA Using R and various computational tools in HCC. Results Detailed results revealed that elevated expression of KNSTRN was considerably associated with bad overall survival (HR = 1.48, 95%CI 1.05–2.09, P = 0.027) and progress free interval (HR = 1.41, 95%CI 1.05–1.89, P = 0.021) in HCC. GO/KEGG functional enrichment analysis showed that KNSTRN is closely related to organelle fission, chromosomal region, tubulin binding, and cell cycle signaling pathway. TIMER databases analysis showed the correlations between KNSTRN expression and tumor-infiltrating immune cells, biomarkers of immune cells and immune checkpoint expression. Moreover, KNSTRN level was significantly positively associated with immunosuppressive cell in tumor microenvironment (TME), including regulatory T cells (Tregs), myeloid derived suppressor cells (MDSCs), and cancer-associated fibrocytes (CAFs). Further, hsa-miR-107 is determined as a potential Nuclear activating miRNA (NamiRNA) by correlation analysis. High expression of hsa-miR-107 is negatively correlated with disease specific survival (HR = 0.62, 95%CI 0.4–0.98, P = 0.04) in patients with HCC by targeting the oncogene, KNSTRN. Finally, a possible NamiRNA-enhancer network of hsa-miR-107 activates the KNSTRN expression in LIHC were constructed. Conclusion The hsa-miR-107-mediated upregulation of KNSTRN correlated with poor prognosis and tumor immune infiltration in HCC.